Literature DB >> 3920704

Effects of multiple pretreatment with apomorphine and amphetamine on amphetamine-induced locomotor activity and its inhibition by apomorphine.

W H Riffee, R E Wilcox.   

Abstract

Mice were given a saline preinjection and habituation to the testing environment followed by injection of amphetamine (0.675-5.0 mg/kg IP) and apomorphine (AP, 15-80 micrograms/kg SC) 15 min later. AP produced a dose-dependent inhibition of the amphetamine-induced locomotor activity. A dose of 40 micrograms/kg AP increased approximately threefold the amphetamine dose required to induce the same increase in activity. Repeated administration of AP (30 mg/kg IP once daily for 14 days) resulted in an enhanced response (in the early portion of the time response) to amphetamine challenge, while the ability of subsequent microgram challenge doses of AP to reduce the response were unaffected. Similarly, repeated administration (twice-daily IP injections for 5 days) of amphetamine (5.0 mg/kg) resulted in an enhanced locomotor response to amphetamine challenge and no change in the ability of AP to inhibit the response. These results suggest that repeated administrations of dopamine agonists, although acting through different mechanisms (i.e., indirect versus direct), increase the initial release of neurotransmitter. However, the repeated administration of these agonists does not attenuate the ability of AP to inhibit the release of the neurotransmitter induced by amphetamine. The regulatory functions (i.e., presynaptic receptor control) of release appears to remain intact, but the level of neuronal activity has been increased.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920704     DOI: 10.1007/bf00427330

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.

Authors:  H L Klawans; D I Margolin
Journal:  Arch Gen Psychiatry       Date:  1975-06

2.  Antipsychotic drugs, neurotransmitters, and schizophrenia.

Authors:  A Carlsson
Journal:  Am J Psychiatry       Date:  1978-02       Impact factor: 18.112

3.  Potentiation of phenothiazines by -methyltyrosine in treatment of chronic schizophrenia.

Authors:  A Carlsson; T Persson; B E Roos; J Wålinder
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

4.  Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.

Authors:  W Kehr; A Carlsson; M Lindqvist; T Magnusson; C Atack
Journal:  J Pharm Pharmacol       Date:  1972-09       Impact factor: 3.765

5.  A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration.

Authors:  R C Bailey; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

6.  Effects of chronic neuroleptic treatment on tyrosine hydroxylase in dopaminergic terminals: comparisons between drugs and brain regions reveals different mechanisms of tolerance.

Authors:  K Gale
Journal:  Adv Biochem Psychopharmacol       Date:  1980

7.  Behavioral facilitation following chronic administration of N-n-propylnorapomorphine.

Authors:  R E Wilcox; W H Riffee; P C Chen; S Hammett; R V Smith
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain.

Authors:  A Carlsson; W Kehr; M Lindqvist
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

9.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

Authors:  P H Kelly; P W Seviour; S D Iversen
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

10.  Plasma levels of apomorphine following intravenous, intraperitoneal and oral administration to mice and rats.

Authors:  R V Smith; R E Wilcox; W H Soine; W H Riffee; R J Baldessarini; N S Kula
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1979-06
View more
  3 in total

1.  Behavioral and biochemical studies of dopamine receptor sensitivity in differentially housed mice.

Authors:  C A Wilmot; C VanderWende; M T Spoerlein
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Effects of subchronic amphetamine or amfonelic acid on rat brain dopaminergic and serotonergic function.

Authors:  B A McMillen; S M Scott; H L Williams
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Experimental catalepsy is both enhanced and disrupted by apomorphine.

Authors:  W R Klemm
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.